Gregory D. Plowman
Direktor/Vorstandsmitglied bei New York Biotechnology Association, Inc.
Profil
Gregory D.
Plowman is currently a Director at New York Biotechnology Association, Inc., AurKa Pharma, Inc., and Acanthas Pharma, Inc. He was previously a Senior Vice President at ImClone LLC, Vice President-Oncology Research at Eli Lilly & Co., and Chief Technology Officer at Exelixis, Inc. Plowman holds a doctorate from the University of Washington and an undergraduate degree from Whitman College.
Aktive Positionen von Gregory D. Plowman
| Unternehmen | Position | Beginn |
|---|---|---|
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
AurKa Pharma, Inc.
 AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - |
Acanthas Pharma, Inc.
 Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Acanthas Pharma, Inc. manufactures pharmaceutical products. The company is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | 19.03.2019 |
Ehemalige bekannte Positionen von Gregory D. Plowman
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Gregory D. Plowman
| Whitman College | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 4 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
AurKa Pharma, Inc.
AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada. | Health Technology |
Acanthas Pharma, Inc.
Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Acanthas Pharma, Inc. manufactures pharmaceutical products. The company is headquartered in Montréal, Canada. | Health Technology |
